# TRIP6

## Overview
TRIP6 is a gene that encodes the protein thyroid hormone receptor interactor 6, a member of the zyxin family of LIM domain proteins. This protein is characterized by its involvement in various cellular processes, including cytoskeletal organization, signal transduction, and transcriptional regulation. The TRIP6 protein contains three LIM domains, which facilitate protein-protein interactions, and is primarily localized at focal adhesions, where it plays a critical role in cell motility and antiapoptotic signaling. Additionally, TRIP6 functions as a transcriptional coactivator in the nucleus, interacting with transcription factors such as NF-κB and c-Fos. Its involvement in telomere protection and various signaling pathways underscores its importance in maintaining cellular homeostasis. Alterations in TRIP6 expression have been implicated in several cancers, highlighting its potential as a diagnostic and therapeutic target (Lin2011TRIP6:; Ling2019TRIP6; Willier2011Defining).

## Structure
TRIP6 is a protein encoded by the TRIP6 gene, characterized by its inclusion in the zyxin family of LIM domain proteins. The protein consists of 476 amino acids and has a molecular mass of approximately 50.3 kDa (Willier2011Defining). Its structure includes three double zinc-finger LIM domains located at the C-terminus, which are crucial for mediating interactions with various proteins (Li2005TRIP6; Willier2011Defining). These LIM domains facilitate protein-protein interactions and are involved in cytoskeleton organization and signal transduction (Cuppen2000The).

The N-terminus of TRIP6 contains multiple proline-rich PXXP motifs, which likely allow it to bind to SH3 domains of other proteins, and five phosphorylation sites, with Tyr 55 being a proven regulatory switch (Willier2011Defining). TRIP6 also features a leucine-rich nuclear export signal (NES) between residues 100 and 107, essential for nuclear export, which can be inhibited by Leptomycin B (Willier2011Defining; Wang2001LIM). The protein shuttles between the nucleus and cytoplasm, a process dependent on its NES and nuclear targeting sequences (Wang2001LIM).

TRIP6 interacts with PDZ motifs in proteins such as RIL and PTP-BL, with its LIM domains playing a significant role in these interactions (Cuppen2000The). The protein is also involved in various signaling pathways, including those mediated by NF-κB and LPA, where it acts as an adaptor linking extracellular signals to transcriptional machinery (Willier2011Defining).

## Function
TRIP6, also known as thyroid hormone receptor interactor 6, is a versatile adaptor protein involved in various cellular processes in healthy human cells. It plays a significant role in cell motility, antiapoptotic signaling, and transcriptional activity. TRIP6 is primarily active at focal adhesions, where it influences cytoskeletal organization and cell migration by interacting with proteins such as paxillin, p130cas, focal adhesion kinase (FAK), and c-Src (Lin2011TRIP6:; Willier2011Defining). 

In the nucleus, TRIP6 acts as a transcriptional coactivator for transcription factors like NF-κB p65 and c-Fos, and it is involved in transcriptional regulation mediated by nuclear hormone receptors, such as the glucocorticoid receptor (GR) (Lin2011TRIP6:). It also plays a role in the anti-inflammatory effects of glucocorticoids by recruiting GR to NF-κB and AP-1 complexes (Lin2011TRIP6:). 

TRIP6 is implicated in telomere protection by interacting with components of the shelterin complex, such as POT1, TRF2, and TIN2, and its depletion can lead to telomere dysfunction (Lin2011TRIP6:). These functions highlight TRIP6's role in maintaining cellular homeostasis and protecting against apoptosis and inflammation in healthy cells.

## Clinical Significance
Alterations in the expression of the TRIP6 gene have significant clinical implications, particularly in cancer. In colorectal cancer (CRC), TRIP6 is overexpressed and associated with poor prognosis, including worse overall survival and disease-specific survival. High TRIP6 expression correlates with advanced tumor stages and poor differentiation, making it a potential diagnostic and prognostic marker for CRC (Liu2024TRIP6; Ling2019TRIP6). TRIP6 also interacts with miR-7, influencing CRC cell proliferation and migration (Liu2024TRIP6).

In gastric cancer, TRIP6 acts as an oncogene, promoting cell growth, proliferation, and migration. Its overexpression is linked to advanced TNM stages and shorter overall survival, suggesting its role in tumor progression (TRIP6; p&gt; Zhu2019&lt). Similarly, in breast cancer, elevated TRIP6 expression is associated with poor prognosis and increased tumorigenicity, highlighting its potential as a therapeutic target (Zhao2020TRIP6).

TRIP6 is also involved in the Wnt/β-catenin signaling pathway, where it interacts with TTPAL to promote colorectal tumorigenesis. This interaction stabilizes TRIP6, enhancing its oncogenic effects (Gou2019TTPAL). In addition to its role in cancer, TRIP6 is crucial for brain ciliogenesis, with mutations leading to ciliopathy-like phenotypes, such as hydrocephalus (Shukla2021TRIP6).

## Interactions
TRIP6, a member of the zyxin family, is involved in various protein-protein interactions that play significant roles in cellular processes. It interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL, forming multiprotein complexes that are crucial for its function in epithelial and endothelial cells (Cuppen2000The). TRIP6 also associates with the LPA2 receptor, promoting cell migration by recruiting proteins such as p130cas, focal adhesion kinase, paxillin, and c-Src to focal adhesion sites (Lai2007PTPL1FAP1; Xu2004TRIP6).

In the context of cancer, TRIP6 interacts with the NF-κB signaling pathway, serving as a transcriptional cofactor and influencing the degradation of IκB, which allows NF-κB to enter the nucleus (Willier2011Defining; Lin2016TRIP6). It also forms a ternary complex with LPAR2 and NHERF2, contributing to anti-apoptotic signaling (Willier2011Defining). TRIP6's interaction with the tumor-suppressor protein SCRIB and its involvement in telomere protection through the shelterin complex highlight its role in maintaining genomic stability and its potential contribution to tumorigenesis (Willier2011Defining).


## References


[1. (Gou2019TTPAL) Hongyan Gou, Jessie Qiaoyi Liang, Lijing Zhang, Huarong Chen, Yanquan Zhang, Rui Li, Xiaohong Wang, Jiafu Ji, Joanna H. Tong, Ka-Fai To, Joseph J.Y. Sung, Francis K.L. Chan, Jing-Yuan Fang, and Jun Yu. Ttpal promotes colorectal tumorigenesis by stabilizing trip6 to activate wnt/β-catenin signaling. Cancer Research, 79(13):3332–3346, July 2019. URL: http://dx.doi.org/10.1158/0008-5472.can-18-2986, doi:10.1158/0008-5472.can-18-2986. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-18-2986)

[2. (Ling2019TRIP6) Yiting Ling, Chenxi Cao, Sengjuan Li, Min Qiu, Guixing Shen, Zhenwei Chen, Fei Yao, and WenBin Chen. Trip6, as a target of mir-7, regulates the proliferation and metastasis of colorectal cancer cells. Biochemical and Biophysical Research Communications, 514(1):231–238, June 2019. URL: http://dx.doi.org/10.1016/j.bbrc.2019.04.092, doi:10.1016/j.bbrc.2019.04.092. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2019.04.092)

[3. (Zhao2020TRIP6) Xiaohui Zhao, Chao Jiang, Rui Xu, Qingnan Liu, Guanglin Liu, and Yan Zhang. Trip6 enhances stemness property of breast cancer cells through activation of wnt/β-catenin. Cancer Cell International, February 2020. URL: http://dx.doi.org/10.1186/s12935-020-1136-z, doi:10.1186/s12935-020-1136-z. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-020-1136-z)

[4. (Lin2011TRIP6:) Victor T.G. Lin and Fang-Tsyr Lin. Trip6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity. Cellular Signalling, 23(11):1691–1697, November 2011. URL: http://dx.doi.org/10.1016/j.cellsig.2011.06.004, doi:10.1016/j.cellsig.2011.06.004. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2011.06.004)

[5. (Shukla2021TRIP6) Shalmali Shukla, Ronny Haenold, Pavel Urbánek, Lucien Frappart, Shamci Monajembashi, Paulius Grigaravicius, Sigrun Nagel, Woo Kee Min, Alicia Tapias, Olivier Kassel, Heike Heuer, Zhao-Qi Wang, Aspasia Ploubidou, and Peter Herrlich. Trip6 functions in brain ciliogenesis. Nature Communications, October 2021. URL: http://dx.doi.org/10.1038/s41467-021-26057-6, doi:10.1038/s41467-021-26057-6. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-26057-6)

[6. (Li2005TRIP6) Lianyun Li, Liang-Hua Bin, Fu Li, Yi Liu, Danying Chen, Zhonghe Zhai, and Hong-Bing Shu. Trip6 is a rip2-associated common signaling component of multiple nf-κb activation pathways. Journal of Cell Science, 118(3):555–563, February 2005. URL: http://dx.doi.org/10.1242/jcs.01641, doi:10.1242/jcs.01641. This article has 49 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.01641)

[7. (Cuppen2000The) Edwin Cuppen, Marco van Ham, Derick G. Wansink, Anuradha de Leeuw, Bé Wieringa, and Wiljan Hendriks. The zyxin-related protein trip6 interacts with pdz motifs in the adaptor protein ril and the protein tyrosine phosphatase ptp-bl. European Journal of Cell Biology, 79(4):283–293, April 2000. URL: http://dx.doi.org/10.1078/s0171-9335(04)70031-x, doi:10.1078/s0171-9335(04)70031-x. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.1078/s0171-9335(04)70031-x)

[8. (Willier2011Defining) Semjon Willier, Elke Butt, Günther H.S. Richter, Stefan Burdach, and Thomas G.P. Grunewald. Defining the role of trip6 in cell physiology and cancer. Biology of the Cell, 103(12):573–591, December 2011. URL: http://dx.doi.org/10.1042/bc20110077, doi:10.1042/bc20110077. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bc20110077)

[9. (Wang2001LIM) Yuan Wang and Thomas D. Gilmore. Lim domain protein trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1538(2–3):260–272, April 2001. URL: http://dx.doi.org/10.1016/s0167-4889(01)00077-5, doi:10.1016/s0167-4889(01)00077-5. This article has 66 citations.](https://doi.org/10.1016/s0167-4889(01)00077-5)

[10. (Lai2007PTPL1FAP1) Yun-Ju Lai, Weei-Chin Lin, and Fang-Tsyr Lin. Ptpl1/fap-1 negatively regulates trip6 function in lysophosphatidic acid-induced cell migration. Journal of Biological Chemistry, 282(33):24381–24387, August 2007. URL: http://dx.doi.org/10.1074/jbc.m701499200, doi:10.1074/jbc.m701499200. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m701499200)

[11. (Liu2024TRIP6) Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, and Zhi-Jun Pei. Trip6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific Reports, February 2024. URL: http://dx.doi.org/10.1038/s41598-024-54670-0, doi:10.1038/s41598-024-54670-0. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-54670-0)

[12. (Lin2016TRIP6) Fang-Tsyr Lin, Vivian Y Lin, Victor T G Lin, and Weei-Chin Lin. Trip6 antagonizes the recruitment of a20 and cyld to traf6 to promote the lpa2 receptor-mediated traf6 activation. Cell Discovery, March 2016. URL: http://dx.doi.org/10.1038/celldisc.2015.48, doi:10.1038/celldisc.2015.48. This article has 14 citations.](https://doi.org/10.1038/celldisc.2015.48)

[13. (Xu2004TRIP6) Jun Xu, Yun-Ju Lai, Weei-Chin Lin, and Fang-Tsyr Lin. Trip6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. Journal of Biological Chemistry, 279(11):10459–10468, March 2004. URL: http://dx.doi.org/10.1074/jbc.m311891200, doi:10.1074/jbc.m311891200. This article has 77 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m311891200)